Abstract
Approximately 75-89% of the peer–reviewed published literature are thought to be non-reproducible. A need exists to better address the problem of irreproducibility of research data so that contradictory, null and negative findings can be disclosed in an unbiased, non-judgemental, yet scientifically plausible manner. Journal of Controversies in Biomedical Research (JCBMR; www.jcbmr.com) is an attempt to address the ‘reproducibility crisis’ in biomedical research. JCBMR is an online-only open access journal that will publish basic science or clinical research articles that meet any of the following criteria: a) original articles that demonstrate biologically plausible negative, neutral or contentious findings; b) original articles that challenge previously published results in peer-reviewed journals; c) original articles that show effects of compounds on disease models (either in vitro or in vivo) are contradictory to the expected outcome; d) review articles that critically evaluate and challenge established norms and offer possible solutions to the problem; e) any manuscript that will assist the scientific community to re-think and re–evaluate the established norm.
Highlights
75-89% of the peer–reviewed published literature are thought to be nonreproducible
A typical biomedical researcher can recall at least one instance in a research career where he or she could not reproduce results that had been published in a peer–reviewed article
Morais and Vitetta Journal of Controversies in Biomedical Research contradictory or negative findings, the policies advocated by funding bodies and research / academic institutions, and the constraints that are placed on authors
Summary
75-89% of the peer–reviewed published literature are thought to be nonreproducible. Morais and Vitetta Journal of Controversies in Biomedical Research contradictory or negative findings, the policies advocated by funding bodies and research / academic institutions, and the constraints that are placed on authors.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
